H. Claeys

1.4k total citations
25 papers, 1.0k citations indexed

About

H. Claeys is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, H. Claeys has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in H. Claeys's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Protease and Inhibitor Mechanisms (6 papers). H. Claeys is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Protease and Inhibitor Mechanisms (6 papers). H. Claeys collaborates with scholars based in Belgium, Switzerland and Denmark. H. Claeys's co-authors include J. Vermylen, C. Vermylen, G. N. J. Tytgat, Marc De Ley, Alfons Billiau, D Collen, Robert Piessens, Piet De Somer, Hans De Beenhouwer and Lars Sottrup‐Jensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Neurology.

In The Last Decade

H. Claeys

25 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Claeys Belgium 17 274 272 242 234 189 25 1.0k
John O. Phillips United States 15 276 1.0× 177 0.7× 74 0.3× 384 1.6× 283 1.5× 26 1.3k
Paul I. Nadler United States 20 190 0.7× 300 1.1× 65 0.3× 222 0.9× 326 1.7× 49 1.0k
E. W. Geddes South Africa 14 351 1.3× 392 1.4× 87 0.4× 217 0.9× 90 0.5× 22 904
Norihiko Yamamoto Japan 25 307 1.1× 295 1.1× 246 1.0× 591 2.5× 492 2.6× 66 1.6k
Christopher Siegel United States 21 269 1.0× 179 0.7× 530 2.2× 535 2.3× 605 3.2× 51 2.4k
Ignacio Herrero Spain 13 496 1.8× 290 1.1× 62 0.3× 196 0.8× 268 1.4× 25 1.2k
Tetsuya Tachikawa Japan 17 251 0.9× 194 0.7× 36 0.1× 596 2.5× 373 2.0× 29 1.2k
H. P. Dienes Germany 20 592 2.2× 481 1.8× 65 0.3× 334 1.4× 210 1.1× 50 1.3k
Kazuo Hatsuse Japan 19 324 1.2× 337 1.2× 182 0.8× 403 1.7× 185 1.0× 53 1.5k
Masaaki Kondo Japan 24 733 2.7× 487 1.8× 140 0.6× 328 1.4× 80 0.4× 91 1.6k

Countries citing papers authored by H. Claeys

Since Specialization
Citations

This map shows the geographic impact of H. Claeys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Claeys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Claeys more than expected).

Fields of papers citing papers by H. Claeys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Claeys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Claeys. The network helps show where H. Claeys may publish in the future.

Co-authorship network of co-authors of H. Claeys

This figure shows the co-authorship network connecting the top 25 collaborators of H. Claeys. A scholar is included among the top collaborators of H. Claeys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Claeys. H. Claeys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emonds, Marie‐Paule, et al.. (1997). An EIA method on single donor solubilized HLA antigens for the identification of anti-HLA antibodies. Clinical & Laboratory Haematology. 19(2). 129–136. 2 indexed citations
2.
Stuyver, Lieven, H. Claeys, Ann Wyseur, et al.. (1996). Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney International. 49(3). 889–895. 86 indexed citations
3.
Nkengasong, John N., Hans De Beenhouwer, H. Claeys, et al.. (1995). A Pilot Study of the Prevalence of Hepatitis C Virus Antibodies and Hepatitis C Virus RNA in Southern Cameroon. American Journal of Tropical Medicine and Hygiene. 52(1). 98–100. 19 indexed citations
4.
Claeys, H., et al.. (1995). Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus. Journal of Medical Virology. 45(3). 273–281. 17 indexed citations
5.
Claeys, H., et al.. (1994). Evaluation of Third‐Generation Screening and Confirmatory Assays for HCV Antibodies. Vox Sanguinis. 66(2). 122–129. 110 indexed citations
6.
Claeys, H., et al.. (1993). Hepatitis C Virus Confirmation in Blood Donor Screening. Vox Sanguinis. 64(3). 145–149. 16 indexed citations
7.
Beenhouwer, Hans De, et al.. (1992). Confirmation of Hepatitis C Virus Positive Blood Donors by Immunoblotting and Polymerase Chain Reaction. Vox Sanguinis. 63(3). 198–203. 25 indexed citations
8.
Claeys, H., et al.. (1992). Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies. Journal of Medical Virology. 36(4). 259–264. 17 indexed citations
9.
Ketelaer, P, et al.. (1986). Transfer factor therapy in multiple sclerosis. Neurology. 36(10). 1399–1399. 3 indexed citations
10.
Ley, Marc De & H. Claeys. (1984). Streptococcal Preparation OK-432-Induced Interferon in Human Leukocytes: Purification and Characterization. International Archives of Allergy and Immunology. 74(1). 21–28. 18 indexed citations
11.
Claeys, H., et al.. (1983). Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients. Journal of the Neurological Sciences. 60(1). 137–150. 32 indexed citations
12.
Claeys, H., Jo Van Damme, Marc De Ley, C. Vermylen, & Alfons Billiau. (1982). Activation of natural cytotoxicity of human peripheral blood mononuclear cells by interferon: a kinetic study and comparison of different interferon types. British Journal of Haematology. 50(1). 85–94. 29 indexed citations
13.
Billiau, Alfons, H. Claeys, Jo Van Damme, et al.. (1981). Interferon therapy in multiple myeloma: Failure of human fibroblast interferon administration to affect the course of light chain disease. European Journal of Cancer and Clinical Oncology. 17(8). 875–882. 8 indexed citations
14.
Damme, Jo Van, Marc De Ley, H. Claeys, et al.. (1981). Inferferon induced in human leukocytes by concanavalin A: isolation and characterization of γ‐ and β‐type components. European Journal of Immunology. 11(11). 937–942. 44 indexed citations
15.
Donati, Maria Benedetta, et al.. (1979). Action of Brinase on Human Fibrinogen and Plasminogen. Thrombosis and Haemostasis. 42(2). 571–581. 4 indexed citations
16.
17.
Claeys, H. & J. Vermylen. (1974). Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Biochimica et Biophysica Acta (BBA) - Protein Structure. 342(2). 351–359. 137 indexed citations
18.
Claeys, H., Abul Hossain Molla, & Matthieu J. Verstraete. (1973). Conversion of NH2-terminal glutamic acid to NH2-terminal lysine human plasminogen by plasmin. Thrombosis Research. 3(5). 515–523. 44 indexed citations
19.
Collen, Désiré, G. N. J. Tytgat, H. Claeys, M Verstraete, & Per Wallén. (1972). Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. Journal of Clinical Investigation. 51(6). 1310–1318. 67 indexed citations
20.
Claeys, H., A Amery, & Raymond Verhaeghe. (1971). Proteolytic Activity of the Activator Produced by Streptokinase in Human Plasma. Thrombosis and Haemostasis. 26(1). 88–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John O. Phillips Breakdown of academic impact, for papers by Paul I. Nadler Breakdown of academic impact, for papers by E. W. Geddes Breakdown of academic impact, for papers by Norihiko Yamamoto Breakdown of academic impact, for papers by Christopher Siegel Breakdown of academic impact, for papers by Ignacio Herrero Breakdown of academic impact, for papers by Tetsuya Tachikawa Breakdown of academic impact, for papers by H. P. Dienes Breakdown of academic impact, for papers by Kazuo Hatsuse Breakdown of academic impact, for papers by Masaaki Kondo
Rankless by CCL
2026